Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Key findings include: Enhanced load-to-failure measurements in healing tendons compared to controls Improved collagen organization and fiber alignment at injury sites Accelerated tendon-to-bone healing in ligament injury models Dose-dependent effects with optimal responses observed at 10 mcg/kg in rodent studies TB-500 research demonstrated enhanced cellular migration and actin polymerization in tendon fibroblasts, while GHK-Cu studies showed increased collagen synthesis and improved tissue remodeling
The ideal candidate for GH-releasing peptide therapy at our clinic is an adult over 35 with subjective symptoms of GH decline (the before profile described earlier) who has had a baseline IGF-1 drawn confirming that GH axis optimization is clinically appropriate
GHK-Cu Dosage (Injectable Protocol) Standard ghk-cu dosage for subcutaneous injection typically ranges from 1 to 3 mg per day, administered 5 days on / 2 days off
Draw 2mL of air into the syringe first
As we age, our levels of HGH naturally decrease, leading to frustrating symptoms like poor sleep, less energy, longer recover times, decreased sex drive, increased fat and less lean muscle, and thinner skin with less elasticity
Stimulating growth factor
US$ 26.97
US$ 28.10
US$ 27.42
US$ 26.54
US$ 28.90
